Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
GAITHERSBURG, Md., Jan. 17, 2008 (PRIME NEWSWIRE) -- VIRxSYS Corporation, a privately held company developing gene therapies for HIV and genetic diseases, today announced that they have signed a...
-
GAITHERSBURG, Md., Sept. 21, 2007 (PRIME NEWSWIRE) -- VIRxSYS Corporation, a privately held company developing gene therapies for HIV and genetic diseases, today announced that it has acquired all the...
-
CHICAGO, Sept. 18, 2007 (PRIME NEWSWIRE) -- VIRxSYS Corporation, a privately held company developing genetic therapies for HIV and genetic diseases, announced today the presentation of a new analysis...
-
GAITHERSBURG, Md., Feb. 20, 2007 (PRIME NEWSWIRE) -- VIRxSYS Corporation announced today that Gerard McGarrity, Ph.D., has joined the company as Executive Vice President of Scientific and Clinical...
-
GAITHERSBURG, Md., Dec. 13, 2006 (PRIME NEWSWIRE) -- VIRxSYS Corporation, a privately held company developing genetic therapies for HIV and cancer, announced a $20 million series G round of financing...
-
GAITHERSBURG, Md., Nov. 6, 2006 (PRIMEZONE) -- VIRxSYS Corporation announced today the publication of results from their Phase I, open-label, non-randomized clinical trial evaluating VRX496, a...